Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Repression of the Type I Interferon Pathway Underlies MYC- and KRAS-Dependent Evasion of NK and B Cells in Pancreatic Ductal Adenocarcinoma
Nathiya Muthalagu, Tiziana Monteverde, Ximena L. Raffo Iraolagoitia, et al.
Cancer Discovery (2020) Vol. 10, Iss. 6, pp. 872-887
Open Access | Times Cited: 139

Showing 26-50 of 139 citing articles:

MYC and KRAS cooperation: from historical challenges to therapeutic opportunities in cancer
Sílvia Casacuberta‐Serra, Íñigo González-Larreategui, Daniel Capitán-Leo, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 11
Cancer cells impair monocyte-mediated T cell stimulation to evade immunity
Anais Elewaut, Guillem Estivill, Felix Bayerl, et al.
Nature (2024)
Open Access | Times Cited: 9
STING Activated Tumor-Intrinsic Type I Interferon Signaling Promotes CXCR3 Dependent Antitumor Immunity in Pancreatic Cancer
Emily P. Vonderhaar, Nicholas S. Barnekow, Donna McAllister, et al.
Cellular and Molecular Gastroenterology and Hepatology (2021) Vol. 12, Iss. 1, pp. 41-58
Open Access | Times Cited: 46
MYC Overexpression Drives Immune Evasion in Hepatocellular Carcinoma That Is Reversible through Restoration of Proinflammatory Macrophages
Renumathy Dhanasekaran, Aida S. Hansen, Jangho Park, et al.
Cancer Research (2022) Vol. 83, Iss. 4, pp. 626-640
Open Access | Times Cited: 35
Epigenetic Repression of STING by MYC Promotes Immune Evasion and Resistance to Immune Checkpoint Inhibitors in Triple-Negative Breast Cancer
Kyung‐min Lee, Chang‐Ching Lin, Alberto Servetto, et al.
Cancer Immunology Research (2022) Vol. 10, Iss. 7, pp. 829-843
Open Access | Times Cited: 31
The immunological landscape in pancreatic ductal adenocarcinoma and overcoming resistance to immunotherapy
Marc Hilmi, Matthieu Delaye, Milena Muzzolini, et al.
˜The œLancet. Gastroenterology & hepatology (2023) Vol. 8, Iss. 12, pp. 1129-1142
Closed Access | Times Cited: 22
CRISPR-Cas9 screening identifies KRAS-induced COX-2 as a driver of immunotherapy resistance in lung cancer
Jesse Boumelha, Andrea de Castro, Nourdine Bah, et al.
Cancer Research (2024) Vol. 84, Iss. 14, pp. 2231-2246
Open Access | Times Cited: 6
LINC00460/miR-186-3p/MYC feedback loop facilitates colorectal cancer immune escape by enhancing CD47 and PD-L1 expressions
Qingqing Luo, Fei Shen, Sheng Zhao, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 6
Loss of MGA repression mediated by an atypical polycomb complex promotes tumor progression and invasiveness
Haritha Mathsyaraja, Jonathen Catchpole, Brian Freie, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 39
Mechanisms Governing Immunotherapy Resistance in Pancreatic Ductal Adenocarcinoma
Zoe C. Schmiechen, Ingunn M. Stromnes
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 33
The interactive role of inflammatory mediators and metabolic reprogramming in pancreatic cancer
Yuuki Ohara, Paloma Valenzuela, S. Perwez Hussain
Trends in cancer (2022) Vol. 8, Iss. 7, pp. 556-569
Open Access | Times Cited: 27
Interplays of glucose metabolism and KRAS mutation in pancreatic ductal adenocarcinoma
Yu-Huei Liu, Chun‐Mei Hu, Yuan-Sheng Hsu, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 9
Open Access | Times Cited: 27
MYC activation impairs cell-intrinsic IFNγ signaling and confers resistance to anti-PD1/PD-L1 therapy in lung cancer
Juan J. Alburquerque-Béjar, Pablo Navajas-Chocarro, Maria Saigí, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 4, pp. 101006-101006
Open Access | Times Cited: 15
An anti-cancer surveillance by the interplay between interferon-beta and retinoblastoma protein RB1
Albert Qin
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 15
Facts and Hopes on RAS Inhibitors and Cancer Immunotherapy
Jesse Boumelha, Míriam Molina‐Arcas, Julian Downward
Clinical Cancer Research (2023) Vol. 29, Iss. 24, pp. 5012-5020
Open Access | Times Cited: 15
MYC in liver cancer: mechanisms and targeted therapy opportunities
Furong Liu, Zhibin Liao, Zhanguo Zhang
Oncogene (2023) Vol. 42, Iss. 45, pp. 3303-3318
Closed Access | Times Cited: 15
Role of interferon regulatory factor 5 (IRF5) in tumor progression: Prognostic and therapeutic potential
Bailey K Roberts, Gilbert Collado, Betsy Barnes
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1879, Iss. 1, pp. 189061-189061
Closed Access | Times Cited: 15
Targeting MYC effector functions in pancreatic cancer by inhibiting the ATPase RUVBL1/2
M. Vogt, Nevenka Dudvarski Stanković, Yiliam Cruz Garcia, et al.
Gut (2024) Vol. 73, Iss. 9, pp. 1509-1528
Open Access | Times Cited: 5
Oncolytic adeno-immunotherapy modulates the immune system enabling CAR T-cells to cure pancreatic tumors
Amanda Rosewell Shaw, Caroline E. Porter, Tiffany Yip, et al.
Communications Biology (2021) Vol. 4, Iss. 1
Open Access | Times Cited: 32
The clinical and molecular significance associated with STING signaling in breast cancer
Eileen E. Parkes, Matthew P. Humphries, Elaine S. Gilmore, et al.
npj Breast Cancer (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 31
Activating Immune Recognition in Pancreatic Ductal Adenocarcinoma via Autophagy Inhibition, MEK Blockade, and CD40 Agonism
Honglin Jiang, Tristan Courau, Joseph Borison, et al.
Gastroenterology (2021) Vol. 162, Iss. 2, pp. 590-603.e14
Open Access | Times Cited: 31
The pathogenesis of mesothelioma is driven by a dysregulated translatome
Stefano Grosso, Alberto Marini, Katarína Gyurászová, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 28
Clinical Strategies Targeting the Tumor Microenvironment of Pancreatic Ductal Adenocarcinoma
Nebojša Skorupan, Mayrel Palestino Domínguez, Samuel L. Ricci, et al.
Cancers (2022) Vol. 14, Iss. 17, pp. 4209-4209
Open Access | Times Cited: 19
Oncogenic drivers dictate immune control of acute myeloid leukemia
Rebecca Austin, Jasmin Straube, Rohit Halder, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 11
Targeting the metabolism and immune system in pancreatic ductal adenocarcinoma: Insights and future directions
Dhana Sekhar Reddy Bandi, Sujith Sarvesh, Batoul Farran, et al.
Cytokine & Growth Factor Reviews (2023) Vol. 71-72, pp. 26-39
Closed Access | Times Cited: 11

Scroll to top